Berthold Akos, Barr Eileen, Kasi Ajay, Lichten Lauren, Hunt William R
Inova Health System, Falls Church, VA, USA.
Department of Human Genetics, Emory University, Atlanta, GA, USA.
Respir Med. 2024 Dec;235:107840. doi: 10.1016/j.rmed.2024.107840. Epub 2024 Oct 29.
People with cystic fibrosis (pwCF) have barriers to physical activity including exercise intolerance and fatigue. The advent of small molecule cystic fibrosis transmembrane conductance regulator (CFTR) modulators have shown great clinical improvements in pwCF; however, the effect of CFTR modulators on exercise perception and participation is unknown. The purpose of this study was to investigate whether the administration of CFTR modulators changed the perception and participation in sport and exercise in pwCF.
A survey-based, retrospective cohort study was conducted including individuals aged 18 and above.
Eighty-three participants were recruited with a mean age of 30.0 ± 10.5 years. The majority (82 %) of participants were taking CFTR modulators. Participants in the modulator group rated enjoyment of exercise and importance of exercise higher than the non-modulator group and were more likely to exercise as a means to socialize. Participants in the modulator group reported lack of time as the most frequent barrier to sport and exercise whereas fatigue was most reported in the non-modulator group. Twenty-eight percent of the modulator group participated in team/structured sports, whereas no participant engaged in team and structured sports in the non-modulator group.
Adults with CF who used CFTR modulators rated exercise more favorably and engaged in more team sport activities compared to pwCF who did not use CFTR modulators. The most frequent barrier to exercise in pwCF who used modulators might no longer be CF-related. More research is needed to confirm whether CFTR modulator administration resulted in increased overall physical activity.
囊性纤维化患者(pwCF)进行体育活动存在障碍,包括运动不耐受和疲劳。小分子囊性纤维化跨膜传导调节因子(CFTR)调节剂的出现已在pwCF患者中显示出巨大的临床改善;然而,CFTR调节剂对运动感知和参与度的影响尚不清楚。本研究的目的是调查CFTR调节剂的使用是否会改变pwCF患者对运动的感知以及参与运动和锻炼的情况。
开展了一项基于调查的回顾性队列研究,纳入18岁及以上的个体。
招募了83名参与者,平均年龄为30.0 ± 10.5岁。大多数参与者(82%)正在服用CFTR调节剂。调节剂组的参与者对运动乐趣和运动重要性的评分高于非调节剂组,并且更有可能将运动作为社交手段。调节剂组的参与者报告称,缺乏时间是运动和锻炼最常见的障碍,而非调节剂组报告最多的是疲劳。调节剂组中有28%的参与者参加团队/有组织的运动,而非调节剂组中没有参与者参加团队和有组织的运动。
与未使用CFTR调节剂的pwCF患者相比,使用CFTR调节剂的成年CF患者对运动的评价更高,并且参与更多的团队运动活动。使用调节剂的pwCF患者运动最常见的障碍可能不再与CF相关。需要更多研究来证实CFTR调节剂的使用是否导致总体身体活动增加。